MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
139 hedge funds and large institutions have $636M invested in Merrimack Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $663M → $636M (-$26.7M)
25% less call options, than puts
Call options by funds: $539K | Put options by funds: $723K
Holders
139
Holding in Top 10
1
Calls
$539K
Puts
$723K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$11.2M | |
| 3 | +$7.43M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$5.88M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.92M |
Top Sellers
| 1 | -$6.76M | |
| 2 | -$5.32M | |
| 3 | -$4.84M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$3.78M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.53M |